Rare Diseases: PKU GOLIKE® debuts in Germany

Balerna (Switzerland), 21st March - PKU GOLIKE®, the...

Winners of the second annual Lyfebulb-Helsinn Innovation Summit & Awards in Oncology announced

Winners of the second annual Lyfebulb-Helsinn Innovation Summit...

Helsinn initiates two new global Phase III studies with anamorelin

▪ Helsinn committed to anamorelin which is being evaluated...